AVITA Medical Files 8-K with Bylaw Amendments
Ticker: AVHHL · Form: 8-K · Filed: May 15, 2025 · CIK: 1762303
| Field | Detail |
|---|---|
| Company | Avita Medical, Inc. (AVHHL) |
| Form Type | 8-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financials
TL;DR
AVITA Medical filed an 8-K on 5/15/25 for bylaw changes and exhibits.
AI Summary
AVITA Medical, Inc. filed an 8-K on May 15, 2025, reporting amendments to its articles of incorporation or bylaws and filing financial statements and exhibits. The company, formerly known as Avita Therapeutics, Inc. and Avita Medical, Ltd., is incorporated in Delaware and has its principal executive offices in Valencia, California.
Why It Matters
This filing indicates potential changes in AVITA Medical's corporate governance or operational structure, which could impact its strategic direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate actions and financial statements, not indicating immediate financial distress or significant operational shifts.
Key Numbers
- 001-39059 — SEC File Number (Identifies the company's filing history with the SEC.)
- 20250515 — Filing Date (Indicates when the report was submitted to the SEC.)
Key Players & Entities
- AVITA Medical, Inc. (company) — Registrant
- May 15, 2025 (date) — Date of earliest event reported
- Avita Therapeutics, Inc. (company) — Former company name
- Avita Medical, Ltd. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Valencia, California (location) — Address of Principal Executive Offices
FAQ
What specific amendments were made to AVITA Medical's articles of incorporation or bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What financial statements and exhibits are being filed with this 8-K?
The filing states that financial statements and exhibits are being filed, but the specific content of these documents is not detailed in the excerpt.
When was AVITA Medical, Inc. previously known as Avita Therapeutics, Inc. and Avita Medical, Ltd.?
The company changed its name from Avita Therapeutics, Inc. on June 30, 2020, and from Avita Medical, Ltd. on December 18, 2018.
What is AVITA Medical, Inc.'s fiscal year end?
AVITA Medical, Inc.'s fiscal year ends on December 31.
Where are AVITA Medical, Inc.'s principal executive offices located?
AVITA Medical, Inc.'s principal executive offices are located at 28159 Avenue Stanford, Suite 220, Valencia, California, 91355.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding AVITA Medical, Inc. (AVHHL).